[1] Pavlidis ET, Pavlidis TE. Current management of concomitant cholelithiasis and common bile duct stones[J]. World J Gastrointest Surg, 2023, 15(2):169-176. [2] Mohseni S, Bass GA, Forssten MP, et al. Common bile duct stones management: a network meta-analysis[J]. J Trauma Acute Care Surg, 2022, 93(5):e155-e165. [3] 杨河, 符敏, 胡军, 等. 胆总管结石患者胆汁和肠道病原菌特点及其与结石复发的相关性[J]. 中国普通外科杂志, 2022, 31(03): 416-420. [4] Schlech WF. Epidemiology and clinical manifestations of listeria monocytogenes infection[J]. Microbiol Spectr, 2019, 7(3):10.1128/microbiolspec.GPP3-0014-2018. [5] 刘立彬, 杨连营, 杜庆云, 等. 胆总管结石合并急性胆管炎患者PTCD胆汁与血培养病原菌分布及耐药性分析[J]. 中华医院感染学杂志, 2019, 29(05): 726-729. [6] Thabit AK. Antibiotics in the Biliary tract: a review of the pharmacokinetics and clinical outcomes of antibiotics penetrating the bile and gallbladder wall[J]. Pharmacotherapy, 2020, 40(7): 672-691. [7] Huemer M, Mairpady Shambat S, et al. Antibiotic resistance and persistence-Implications for human health and treatment perspectives[J]. EMBO Rep, 2020, 21(12):e51034. [8] Osaki T, Lin Y, Sasahira N, et al. Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers[J]. Helicobacter, 2022, 27(1):e12866. [9] Jiang T, Wang Z, Aji T, et al. ERCP management of acute cholangitis caused by rupture of Echinococcus hepaticus into the biliary tract[J]. J Minim Access Surg, 2023, 19(4):498-503. [10] Zhang R, Liu J, Li H, et al. Evaluation of therapeutic efficacy, safety and economy of ERCP and LTCBDE in the treatment of common bile duct stones[J]. Front Physiol, 2022, 13:949452. [11] Christaki E, Marcou M, Tofarides A. Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence[J]. J Mol Evol, 2020, 88(1):26-40. [12] Bader MS, Loeb M, Leto D, et al. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents[J]. Postgrad Med, 2020, 132(3):234-250. [13] 中华医学会外科学分会胆道外科学组. 急性胆道系统感染的诊断和治疗指南(2021版)[J]. 中华外科杂志, 2021, 59(6):422-429. [14] Serra N, Di Carlo P, Gulotta G, et al. Bactibilia in women affected with diseases of the biliary tract and pancreas. A STROBE guidelines-adherent cross-sectional study in Southern Italy[J]. J Med Microbiol, 2018, 67(8):1090-1095. [15] Grigor'eva IN, Romanova TI. Gallstone disease and microbiome[J]. Microorganisms, 2020, 8(6):835. [16] Johnson KD, Perisetti A, Tharian B, et al. Endoscopic retrograde cholangiopancreatography-related complications and their management strategies: a “scoping” literature review[J]. Dig Dis Sci, 2020, 65(2):361-375. [17] Liu J, Wei X J, Yang Z L, et al. Risk factors of common bile duct stones recurrence and nomogram for predicting recurrence after endoscopic retrograde cholangiopancreatography: a dual-center retrospective cohort study[J]. Eur Rev Med Pharmacol Sci, 2023, 27(6): 2504-2513. [18] 黄瑶, 易剑锋, 周文策. 胆总管结石治疗后复发因素的研究进展[J]. 中国普通外科杂志, 2021, 30(08): 964-70. |